GuidelineJournal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC2006
Canadian Consensus Conference on osteoporosis, 2006 update.
Guideline in Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- An interdisciplinary knowledge translation intervention in long-term care: study protocol for the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.Implementation science : IS · 2012Trial
- Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012Trial
- Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021Article
- Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women.Frontiers in pharmacology · 2021Article
- Urinary phytate concentration and risk of fracture determined by the FRAX index in a group of postmenopausal womenTurkish journal of medical sciences · 2019Article
- Article
- Evaluation of Bone Mineral Density in Perimenopausal Period.The archives of bone and joint surgery · 2018Article
- Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.Clinical oral investigations · 2017Article
- Normal range of BMD in proximal tibia as a different skeletal site at women.Northern clinics of Istanbul · 2016Article
- Estimation of 10-year probability bone fracture in a selected sample of Palestinian people using fracture risk assessment tool.BMC musculoskeletal disorders · 2013Article
- Article
- An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2013Article
- Denosumab: mechanism of action and clinical outcomes.International journal of clinical practice · 2012Review
- Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012Article
- How applicable are clinical practice guidelines to elderly patients with comorbidities?Canadian family physician Medecin de famille canadien · 2011Review
- Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines.Canadian family physician Medecin de famille canadien · 2011Article
- Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene.Expert opinion on pharmacotherapy · 2011Review
- Calcium citrate and vitamin D in the treatment of osteoporosis.Clinical drug investigation · 2011Review
- Closing the osteoporosis care gap in hip fracture patients: an opportunity to decrease recurrent fractures and hospital admissions.Journal of osteoporosis · 2011Article
- Usability evaluation of a clinical decision support tool for osteoporosis disease management.Implementation science : IS · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo provide guidelines for the health care provider on the diagnosis and clinical management of postmenopausal osteoporosis. OUTCOMES: Strategies for identifying and evaluating high-risk individuals, the use of bone mineral density (BMD) and bone turnover markers in assessing diagnosis and response to management, and recommendations regarding nutrition, physical activity, and the selection of pharmacologic therapy to prevent and manage osteoporosis. EVIDENCE: MEDLINE and the Cochrane database were searched for articles in English on subjects related to osteoporosis diagnosis, prevention, and management from March 2001 to April 2005. The authors critically reviewed the evidence and developed the recommendations according to the Journal of Obstetrics and Gynaecology Canada's methodology and consensus development process. VALUES: The quality of evidence is rated using the criteria described in the report of the Canadian Task Force on the Periodic Health Examination. Recommendations for practice are ranked according to the method described in this report. SPONSORS: The development of this consensus guideline was supported by unrestricted educational grants from Berlex Canada Inc., Lilly Canada, Merck Frosst, Novartis, Novogen, Novo Nordisk, Proctor and Gamble, Schering Canada, and Wyeth Canada.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.